Fig. 3: Taurine attenuates P + M-induced dopaminergic neurodegeneration and α-synuclein aggregation. | Cell Death & Disease

Fig. 3: Taurine attenuates P + M-induced dopaminergic neurodegeneration and α-synuclein aggregation.

From: Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization

Fig. 3

a Taurine was administrated to mice prior to 30 min of P + M exposure. After 6 weeks of P + M treatment, dopaminergic neurons were immunostained with antibody against TH and the representative images were shown. b The number of TH+ neurons in the SNpc was quantified. c After 6 weeks of treatment, the expression of α-synuclein in midbrain was detected by using western blot and the representative blots were shown. GAPDH was used as an internal control. d The band density of blots was quantified. *p < 0.05, **p < 0.01; Scale bar = 200 μm

Back to article page